ZoomInfo earnings beat by $0.02, revenue topped estimates

ZoomInfo reported Q1 EPS of $0.28, beating the $0.26 consensus, and revenue of $310.2M versus $307.95M expected. However, Q2 revenue guidance of $300M-$303M and FY 2026 revenue guidance of $1.19B-$1.21B both came in below analyst expectations, offsetting the modest beat. Shares closed at $6.04, with the stock down 41.42% over the past 12 months.

Analysis

GTM’s setup is less about the beat and more about the quality of the miss in forward numbers: management is signaling a narrower near-term conversion window than the market had embedded, while consensus still appears to be anchored to a stabilization narrative. That combination usually compresses multiple expansion even when headline EPS is fine, because the equity is already pricing an eventual re-acceleration that may not show up until late 2026. With the stock already heavily de-rated, the near-term reaction should be driven more by estimate cuts than by the quarter itself.

The second-order read-through is to the broader software budget cycle: if a scaled GTM platform is guiding below street on revenue while maintaining modest profitability, it suggests customers are still scrutinizing spend and elongating sales cycles rather than broad-based demand deterioration. That is constructive for lower-cost point solutions and workflow tools that can win share on ROI, but it is a headwind for bundled GTM/RevOps platforms that depend on expansion and seat growth. In practice, this argues for relative value within software rather than a blanket sector call.

The contrarian angle is that the stock may already be pricing a worst-case normalization, so the risk is not further downside on the quarter but a failure to benefit from any macro stabilization over the next 1-2 quarters. If revisions stop deteriorating and management shows even modest sequential improvement, the tape could re-rate fast from a depressed base. Until then, the path of least resistance is still lower because guidance cuts tend to matter more than small EPS beats in names trading at single-digit prices.

The main catalyst path is the next two prints: if Q2 guides down again, the market will likely treat FY26 as at risk of another reset and press the stock toward prior cycle lows. If instead bookings and net retention stabilize, a squeeze is possible given the large year-over-year drawdown and crowded negative sentiment. The inflection point to watch is whether management can re-accelerate revenue without sacrificing margin, because that would shift GTM from a value trap to a selective recovery story.

Key Decisions for Investors

• Short GTM on any post-earnings bounce above $6.25-$6.50 over the next 1-2 weeks; risk/reward favors a retest of prior lows if sell-side cuts continue to roll in.
• For a cleaner relative-value expression, long a higher-quality software name with stable guidance and short GTM as a pair trade over the next quarter; this isolates execution risk from sector beta.
• Buy GTM put spreads 1-2 months out rather than outright puts; the thesis is estimate compression, so defined-risk downside should outperform if the market reprices FY26 lower.
• If GTM holds above $6 and consensus revisions flatten for 2-3 weeks, cover shorts and consider a tactical long trade only on evidence of sequential improvement in bookings or guidance cadence.